Screener
Stepan SCL Surfactants — Unallocated Capital Expenditures Income
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Stepan in its filing.
Tagged under the XBRL concept scl:UnallocatedCapitalExpendituresIncome.
The source filing: Stepan’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 12:37 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-334428
| (In thousands) | Surfactants | Polymers | Specialty Products | Total |
|---|---|---|---|---|
| Unallocated Corporate Expenses (3) | — | — | — | (24,628) |
| Consolidated Operating Income | $37,210 | |||
| Segment Capital Expenditures | $16,057 | $6,517 | $992 | $23,566 |
| Unallocated Capital Expenditures (4) | — | — | — | (160) |
| Consolidated Capital Expenditures | $23,406 | |||
| Segment Depreciation and Amortization | $20,520 | $8,698 | $1,467 | $30,685 |
| Unallocated Depreciation and Amortization (5) | — | — | — | 235 |
| Consolidated Depreciation and Amortization | $30,920 |
Item 1 - Financial Statements
FAQ
- What is Stepan's surfactants — unallocated capital expenditures income?
- Stepan (SCL) reported surfactants — unallocated capital expenditures income of $0 in Q2 2026.
- What does surfactants — unallocated capital expenditures income mean?
- This metric represents income or financial benefits derived from capital expenditures that are managed centrally rather than allocated to the specific surfactants segment. It highlights the impact of corporate-level investment strategies on the overall financial profile of the segment. Understanding these inflows is necessary to reconcile segment-level performance with total company capital efficiency.
Ask your AI about Stepan's surfactants — unallocated capital expenditures income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude